Key facts
- This page summarizes Catherine M. Burzik's Form 4 filing for Orthofix Medical Inc. (OFIX).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 09 Apr 2024, 16:54.
Catherine M. Burzik - 08 Apr 2024 Form 4 Insider Report for Orthofix Medical Inc. (OFIX)
- Reporting relationship
- Director
- Issuer ticker
- OFIX
- Reported as of
- 08 Apr 2024
- Net transaction value
- -$675,726
- SEC form
- 4
- Accepted by SEC
- 09 Apr 2024, 16:54:46 UTC
- Prior SEC filing
- 25 Jan 2024
- Next SEC filing
- 30 Jan 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Kimberley A. Elting, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Catherine M. Burzik filed Form 4 for Orthofix Medical Inc. (OFIX) on 09 Apr 2024.
Change
- Previous filing in this sequence was filed on 25 Jan 2024.
- Current net transaction value: -$675,726.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
OFIX
transaction
Common Stock
Tax liability
- Transaction value
- $675,726
- Shares
- -47,486
- Change %
- -30%
- Price
- $14.23
- Shares after
- 112,803
- Date
- 08 Apr 2024
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Includes 32,763 previously reported deferred stock units.